Vertex' $2.7B in CRE Value

Can you pick anyone out through the confetti? Vertex Pharmaceuticals is generating $2.7B in real estate activity at Fan Pier with the $900M, 1.1M SF build-to-suit complex that The Fallon Company started building for it in June. Add to that the lease  payments (as much as $1.8B-plus operating costs over 15 years)and it's easy to see why the summer groundbreaking looked and felt more like New Year?s Eve. The life science company's relo from its longtime Cambridge HQ has also infused confidence among other developers who have a few billion dollars more in projects in the works at the Seaport.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

Federal Government To Sell Nearly 31K SF In Five Points: The Denver Deal Sheet

Avison Young Had Assets Frozen By Bank Over Unpaid Taxes

Artificial Intelligence Companies Reshaping Dublin Office Demand As OpenAI Confirms HQ

Mars Factory Overhaul Stalls As Candymaker's Chicago Expansion Accelerates

Camden Property Trust Sells West Coast Portfolio, Clears $1.5B Target

Boston Property Owners Raise Alarms About Cost Of Electric-Building Push

Empire State Building Observation Deck Hemorrhaging Visitors, Value

Cortland, Pulte, INVH, Walker & Dunlop Execs Talk Changing Demographics, AI

America's War Machine Is Growing, Sparking A Defense Real Estate Boom

Clarion Under Contract To Sell 18-Story Seaport Office Tower

Boca Raton's New Leaders Throwing 'All Kinds Of Curveballs' At Developers

CBRE Posts 16% Revenue Growth In Q2 As Data Center Business Shines